TABLE 1.
PSC Patients With GF According to Wait-List Status and Re-LT
| Not Relisted (n = 1041) |
Relisted (n = 762) |
P Value | Not Retransplanted (n = 126) |
Retransplanted (n = 636) |
P Value | |
|---|---|---|---|---|---|---|
| Age* | 53 (43–61) | 42 (33–52) | <0.001 | 51 (41–58) | 45 (36–55) | 0.002 |
| Male sex | 685 (65.8) | 550 (72.2) | 0.004 | 86 (68.3) | 464 (73.0) | 0.28 |
| Race/ethnicity | 0.28 | 0.44 | ||||
| White | 845 (81.2) | 620 (81.4) | 98 (77.8) | 525 (82.5) | ||
| Black | 128 (12.3) | 106 (13.9) | 22 (17.5) | 82 (12.9) | ||
| Hispanic | 51 (4.9) | 28 (3.7) | 4 (3.2) | 22 (3.5) | ||
| Asian | 13 (1.2) | 4 (0.5) | 1 (0.8) | 5 (0.8) | ||
| Other | 4 (0.4) | 4 (0.5) | 1 (0.8) | 2 (0.3) | ||
| Blood type | 0.23 | 0.54 | ||||
| A | 434 (41.7) | 312 (40.9) | 55 (43.7) | 256 (40.3) | ||
| B | 110 (10.6) | 103 (13.6) | 16 (12.7) | 88 (13.8) | ||
| AB | 44 (4.2) | 36 (4.7) | 3 (2.4) | 33 (5.2) | ||
| O | 453 (43.5) | 311 (40.8) | 52 (41.3) | 259 (40.7) | ||
| IBD | 731 (70.2) | 548 (71.9) | 0.43 | 87 (69.0) | 461 (72.5) | 0.43 |
| Ulcerative colitis | 495 (47.6) | 370 (48.6) | 0.67 | 62 (49.2) | 308 (48.4) | 0.87 |
| Crohn’s disease | 177 (17.0) | 123 (16.1) | 0.63 | 19 (15.1) | 104 (16.4) | 0.72 |
| Other | 59 (5.7) | 55 (7.2) | 0.18 | 6 (4.8) | 49 (7.7) | 0.24 |
| Insurance* | <0.001 | 0.24 | ||||
| Private | 739 (71.3) | 609 (80.3) | 85 (68.0) | 470 (73.9) | ||
| Medicaid | 71 (6.8) | 46 (6.1) | 6 (4.8) | 38 (6.0) | ||
| Medicare | 189 (18.2) | 72 (9.5) | 29 (23.2) | 100 (15.7) | ||
| Other | 38 (3.7) | 31 (4.1) | 5 (4.0) | 28 (4.4) | ||
| Education*,† | <0.001 | 0.04 | ||||
| High school | 315 (42.8) | 184 (33.0) | 35 (40.7) | 138 (29.6) | ||
| Some college or beyond | 421 (57.2) | 373 (67.0) | 51 (59.3) | 329 (70.4) | ||
| UNOS region* | 0.24 | 0.85 | ||||
| 1 | 42 (4.0) | 29 (3.8) | 6 (4.8) | 21 (3.3) | ||
| 2 | 107 (10.3) | 82 (10.8) | 16 (12.7) | 66 (10.4) | ||
| 3 | 147 (14.1) | 103 (13.5) | 13 (10.3) | 97 (15.3) | ||
| 4 | 86 (8.3) | 42 (5.5) | 7 (5.6) | 36 (5.7) | ||
| 5 | 120 (11.5) | 77 (10.1) | 13 (10.3) | 67 (10.5) | ||
| 6 | 37 (3.6) | 19 (2.5) | 4 (3.2) | 15 (2.4) | ||
| 7 | 128 (12.3) | 110 (14.4) | 19 (15.1) | 81 (12.7) | ||
| 8 | 101 (9.7) | 82 (10.8) | 10 (7.9) | 73 (11.5) | ||
| 9 | 53 (5.1) | 54 (7.1) | 11 (8.7) | 42 (6.6) | ||
| 10 | 110 (10.6) | 87 (11.4) | 15 (11.9) | 76 (11.9) | ||
| 11 | 110 (10.6) | 77 (10.1) | 12 (9.5) | 62 (9.7) | ||
| Living donor recipient | 64 (6.1) | 79 (10.4) | 0.001 | 10 (7.9) | 69 (10.8) | 0.32 |
| DCD recipient | 16 (1.5) | 28 (3.7) | 0.004 | 3 (2.4) | 25 (4.0) | 0.60 |
| Etiologies of GF‡ | ||||||
| VT | 20 (8.1) | 209 (31.7) | <0.001 | 14 (15.7) | 195 (34.2) | <0.001 |
| REC | 80 (32.4) | 207 (31.4) | 0.78 | 26 (29.2) | 181 (31.8) | 0.63 |
| PNF | 52 (21.1) | 144 (21.9) | 0.79 | 15 (16.9) | 129 (22.6) | 0.22 |
| BCs | 32 (13.0) | 136 (20.6) | 0.008 | 14 (15.7) | 122 (21.4) | 0.22 |
| CR | 40 (16.2) | 93 (14.1) | 0.43 | 10 (11.2) | 83 (14.6) | 0.40 |
| AR | 18 (7.3) | 55 (8.3) | 0.60 | 7 (7.9) | 48 (8.4) | 0.86 |
| INF | 61 (24.7) | 64 (9.7) | <0.001 | 22 (24.7) | 42 (7.4) | <0.001 |
| Other | 73 (29.6) | 61 (9.3) | <0.001 | 15 (16.9) | 46 (8.1) | 0.008 |
| Multiple etiologies of GF‡ | 84 (34.0) | 235 (35.7) | 0.64 | 26 (29.2) | 209 (36.7) | 0.17 |
NOTE: Data are given as n (%) or median (IQR).
*
For comparison of relisted and not relisted, variable extracted from primary LT event. After relisting, represents status at wait-list registration. Distribution of data in retransplanted and not retransplanted may therefore vary slightly from total in relisted column.
†
Available for 736/1041 not relisted, 557/762 relisted, 86/126 not retransplanted, and 467/636 retransplanted.
‡
Available for 247/1041 not relisted, 659/762 relisted, 89/126 not retransplanted, and 570/636 retransplanted. Percentages expressed as a proportion of those with a reported etiology.